Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: United Kingdom Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20071
20084
20094
20103
20113
20122
20133
20141
20151
20163
20172
20184
20194
20201
20215
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion11
United Therapeutics6
Bial - Portela C S.A.5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Bayer3
Novartis Pharmaceuticals3
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Papworth Hospital NHS Foundation Trust2
Altavant Sciences GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension51
Hypertension, Pulmonary15
Familial Primary Pulmonary Hypertension3
Hypertension3
Cardiovascular Diseases2
Heart Failure2
Iron Deficiencies2
Adenoviridae Infections1
Aneurysm1
Anxiety Disorders1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.